21 CFR 25.21 - Extraordinary circumstances.
As required under 40 CFR 1508.4, FDA will require at least an EA for any specific action that ordinarily would be excluded if extraordinary circumstances indicate that the specific proposed action may significantly affect the quality of the human environment (see 40 CFR 1508.27 for examples of significant impacts). Examples of such extraordinary circumstances include:
(a) Actions for which available data establish that, at the expected level of exposure, there is the potential for serious harm to the environment; and
(b) Actions that adversely affect a species or the critical habitat of a species determined under the Endangered Species Act or the Convention on International Trade in Endangered Species of Wild Flora and Fauna to be endangered or threatened or wild flora or fauna that are entitled to special protection under some other Federal law.
Title 21 published on 2014-04-01
no entries appear in the Federal Register after this date.